related Glioblastoma conserved motif-like peptide domains. These results demonstrate that the VDAC1 treating CLL peptides may assist target-fishing approaches that are currently ubiquitous in cheminformatics
using automated karyotyping (IKAROS) soft ware in Leukemia cancer (CML, AML, ALL and CLL) samples. Methods: Conventional cytogenetics: Peripheral Blood Culture (PBC) and bone marrow aspirate supplemented with mitogen…
Chronic lymphocytic leukemia (CLL) is a clonal expansion of small mature lymphocytes accumulating in blood, bone marrow, and lymphoid organs. CLL is characterized by extremely variable clinical courses with survivals
Treatment of Chronic Lymphocytic Leukemia (CLL) is entering a new era. In the last 5 years, several new exciting drugs have entered the realm in hopes for a success ... agents with established chemotherapy and…
selected during a long evolution in the fight for fitness. Since the susceptibility for CLL has a genotype, a theoretical question about its advantage is relevant. This is a question ... adult life of the offspring…
cell neoplasms, and its prognostic role in B cell chronic lymphocytic leukaemias (B-CLL). CD26 expression was evaluated by flow cytometry in various B cell neoplasms. CD26 expression was high ... expression CD26, CD38…
Chronic lymphocytic leukemia (CLL) is a mature B-cell lymphoid neoplasm characterized by the proliferation and accumulation of small CD5/CD19/CD23-positive lymphocytes in the blood, lymph nodes, spleen ... cases in 2014…
studies, and showed promising antitumor activity in patients with chronic lymphocytic leukemia (CLL). Moxetumomab pasudotox is currently undergoing phase 1 testing in refractory HCL, as well as in CLL
patients showed morphological features of cells typical for chronic lymphocytic leukemia (CLL), (small lymphocytes, clumped chromatin, scanty cytoplasm) in all cases, compatible with FCI. 7 out of 195 patients have…
patients with LPD complicated by renal failure, chronic lymphocytic leukemia/small cell lymphocytic lymphoma (CLL/SLL, n=3) and marginal zone lymphoma (MZL, n=2). Median age of patients ... patients without infection…
leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL), each with distinct characteristics and progression rates. The exact causes of leukemia remains…
Chronic lymphocytic leukemia (CLL) is a danger of CD5+ B cells that is described by the gathering of little, mature-seeming lymphocytes in the blood, marrow and lymphoid tissues. Flagging
Schizophrenia (TRS) on clozapine medication for almost eight years, who developed Chronic Lymphocytic Leukemia (CLL). We also performed a literature review using the pubmed database regarding the hematological…
examinations disclosed a spleen spontaneous rupture. The treatment consisted of a ablation. Chronic leukaemia (CLL) could be a sort of cancer of the blood and bone marrow — the spongy tissue
present a case of a 55-year-old patient with a history of CLL (Chronic Lymphocytic Leukemia), who had encephalitis seventeen days post vaccination. Although the benefits outweigh the risk
leukemias Conclusion: The commonest type of leukemia observed in this study was CML and CLL was less frequent. In almost all age groups and types of leukemias, males predominated
Evans syndrome is most often associated with hematological malignancies such as Chronic Lymphocytic Leukemia (CLL) or Non-Hodgkin Lymphoma (NHL), and while exceedingly rare, ES has also been reported
have been reported. Several other markers were claimed to characterize LSCs including CD33, CD45RA, CLL-1, TIM-3, CD47, CD96, IL-1 receptor accessory protein (IL1RAP), CD25, CD93, CD70/CD27
Constant lymphocytic leukemia (CLL) is a kind of malignancy wherein the bone marrow makes an excessive number of lymphocytes (a sort of white platelet). From the beginning there are normally
approach - is showing great promise in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). While chemotherapy, drugs that directly kill cells, remains an important component of many treatment regimens
This is a potent drug which is specifically targeted for relapsed chronic lymphocytic leukemia (CLL). Methods and Findings: A full replicate bioequivalence study of two Idelalisib 150 mg tablets
varying levels of expression of stem cell markers like ABCG2, CD90, CD96, CD123, CXCR4, CLL-1 and other genes like Wnt3A, TERT, Notch1, Nanog, Sox2, Oct4, BMI1, βCat
EDHM) is a rare cutaneous reaction associated with hematologic malignancies, including Chronic Lymphocytic Leukemia (CLL). The lesions clinically and histologically resemble insect bites; however, in most cases the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.